{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T17:35:20Z","timestamp":1648748120883},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"S5","license":[{"start":{"date-parts":[[1990,9,1]],"date-time":"1990-09-01T00:00:00Z","timestamp":652147200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drug Ther"],"published-print":{"date-parts":[[1990,9]]},"DOI":"10.1007\/bf02018297","type":"journal-article","created":{"date-parts":[[2005,8,12]],"date-time":"2005-08-12T02:33:18Z","timestamp":1123813998000},"page":"941-945","source":"Crossref","is-referenced-by-count":2,"title":["Long-term therapy with slow-release nifedipine in essential hypertension"],"prefix":"10.1007","volume":"4","author":[{"given":"Francesco","family":"Arrigo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fausto","family":"Consolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02018297_CR1","first-page":"208","volume":"45","author":"K Hagino","year":"1968","unstructured":"Hagino K. Application of ipoveratrial in the pharmacotherapy of hypertension.Jpn J Clin Exp Med 1968;45:208\u2013213.","journal-title":"Jpn J Clin Exp Med"},{"key":"BF02018297_CR2","first-page":"292","volume-title":"Calcium antagonits in cardiovascular therapy","author":"A Zanchetti","year":"1981","unstructured":"Zanchetti A. Perspectives in antihypertensive treatment. In: Zanchetti A, Krikler D edsCalcium antagonits in cardiovascular therapy. Amsterdam: Excerpta Medica, 1981:292."},{"key":"BF02018297_CR3","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/00005344-198200433-00013","volume":"4","author":"G Muiesan","year":"1982","unstructured":"Muiesan G, Agabiti rosei E, et al. Antihypertensive and homoral effects of verapamil and nifedipine in essential hypertension.J Cardiovasc Pharmacol 1982:4:S325.","journal-title":"J Cardiovasc Pharmacol"},{"key":"BF02018297_CR4","first-page":"334","volume":"22","author":"G Grun","year":"1972","unstructured":"Grun G, Fleckenstein A. Die elektromechanische entkopplung der glatten gesfassumskulatur als grundprinzip der coronardilatationdurch 4-(2-nitrophenyl)-2, 6-dimethyl-1,4-dihydropirindin-c arbosaure-dimethylester (Bay 1040, nifedipine).Arzneim-Forsch (Drug Reserach) 1972:22:334\u2013343.","journal-title":"Arzneim-Forsch (Drug Reserach)"},{"key":"BF02018297_CR5","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1365-2125.1980.tb01784.x","volume":"10","author":"BF Robinson","year":"1980","unstructured":"Robinson BF, Dobbs RJ, Kelsey CR. Effects of nifedipine on resistance vessels, arteries and veins in man.Br J Clin Pharmacol 1980:10:433\u2013439.","journal-title":"Br J Clin Pharmacol"},{"key":"BF02018297_CR6","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1536\/ihj.13.128","volume":"13","author":"M Murakami","year":"1972","unstructured":"Murakami M, Murakami E, Takekoshi N et al. Antihypertensive effect of nifedipine, a new coronary dilator.Jpn Heart J 1972;13:128\u2013135.","journal-title":"Jpn Heart J"},{"key":"BF02018297_CR7","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1161\/01.CIR.59.5.1056","volume":"59","author":"MT Olivari","year":"1979","unstructured":"Olivari MT, Bartorelli C, Polese A, et al. Treatment of hypertension with nifedipine, a calcium antagonist agent.Circulation 1979:59:1056\u20131060.","journal-title":"Circulation"},{"issue":"Suppl II","key":"BF02018297_CR8","first-page":"29","volume":"5","author":"AM Taburet","year":"1983","unstructured":"Taburet AM, Singlas E, Colin JN, et al. Pharmacokinetic studies on nifedipine tablet: Correlation with antihypertensive effects.Hypertension 1983;5(Suppl II):29","journal-title":"Hypertension"},{"key":"BF02018297_CR9","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1136\/bmj.287.6387.257","volume":"287","author":"MB Murphy","year":"1983","unstructured":"Murphy MB, Scriven AJI, Dollery CT, Role of nifedipine in the treatment of hypertension.Br Med J 1983:287:257\u2013262.","journal-title":"Br Med J"},{"key":"BF02018297_CR10","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00005344-198501000-00024","volume":"7","author":"D Bonaduce","year":"1985","unstructured":"Bonaduce D, Canonico, V, Mazza F et al. Evaluation of the efficacy of slow release nifedipine in systemic hypertension by ambulatory intraarterial blood pressure monitoring.J Cardiovasc Pharmacol 1985:7:145\u2013151.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"Suppl III","key":"BF02018297_CR11","first-page":"21","volume":"5","author":"J Menard","year":"1983","unstructured":"Menard J, Chatellier G, Degoulet P et al. How much can blood presure be lowered?Hypertension 1983:5(Suppl III):21.","journal-title":"Hypertension"},{"key":"BF02018297_CR12","first-page":"1261","volume":"1","author":"Management Committee","year":"1980","unstructured":"Management Committee. The Australian Therapeutic trial in mild hypertension.Lancet 1980:1:1261\u20131267.","journal-title":"Lancet"},{"key":"BF02018297_CR13","first-page":"375","volume":"18","author":"G Leonetti","year":"1980","unstructured":"Leonetti G, Sala C, Bianchini C et al. Antihypertensive and renal effects of orally administered verapamil.Eur J Pharmacol 1980:18:375\u2013382.","journal-title":"Eur J Pharmacol"},{"key":"BF02018297_CR14","first-page":"196","volume-title":"Proc 1 st Int Can Nifedipine Symp","author":"PD Henry","year":"1983","unstructured":"Henry PD. Calcium antagonist as cell protectant. In: Terroux P, Waters DD, edsProc 1 st Int Can Nifedipine Symp. Amsterdam: Exceepta Medica, 1983:196."},{"key":"BF02018297_CR15","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/eurheartj\/1.suppl_2.5","volume":"1","author":"WG Nayler","year":"1980","unstructured":"Nayler WG, Calcium antagonist.Eur Heart J 1980:1:225\u2013238.","journal-title":"Eur Heart J"},{"key":"BF02018297_CR16","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1185\/03007998709111110","volume":"10","author":"P Schnapp","year":"1986","unstructured":"Schnapp P, Hermamm H, Cernak P, Kalay J. Nifedipine monotherapy in the hypertensive elderly: A placebocontrolled clinical trial.Curr Med res Opin 1986:10:407\u2013413.","journal-title":"Curr Med res Opin"},{"issue":"Suppl II","key":"BF02018297_CR17","first-page":"97","volume":"5","author":"P Erne","year":"1983","unstructured":"Erne P, Bolci P, Bertel O, et al. Factors influenceng the hypotension effect of calcium antagonists.Hypertension 1983:5(Suppl II):97\u2013102.","journal-title":"Hypertension"},{"key":"BF02018297_CR18","unstructured":"Midtbo K. Efficacious and safe. In: Calcium antagonists\u2014New perspectives. Oxford Medical Education Service, 1985:6."},{"key":"BF02018297_CR19","first-page":"25","volume":"78","author":"M Thibonnier","year":"1985","unstructured":"Thibonnier M, Sassano P, Corvol P. Evaluation de l'effect antihypertenseur des formes capsule et comprim\u00e9 de nifedipine dans l'hypertension.Arch Mal Coeur 1985:78:25\u201331.","journal-title":"Arch Mal Coeur"},{"key":"BF02018297_CR20","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/S0140-6736(76)91737-2","volume":"1","author":"RB Haynes","year":"1976","unstructured":"Haynes RB, Sackett DL, Gibson ES et al. Improvement of medication compliane in uncontrolled hypertension.Lancet 1976:1:1265.","journal-title":"Lancet"},{"key":"BF02018297_CR21","first-page":"333","volume-title":"Calcium antagonistis and cardiovascular disease","author":"LH Opie","year":"1984","unstructured":"Opie LH, Jee LD, Nifedipine: Exanding indications in hypertension. in: Opie LH, ed.Calcium antagonistis and cardiovascular disease. New York: Raven Press 1984:333\u2013342."},{"key":"BF02018297_CR22","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/0002-9149(83)90306-5","volume":"51","author":"RS Hornung","year":"1983","unstructured":"Hornung RS, Gould BA, Jones RI, et al. Nifedipine tablest for hypertension: A study using continous ambulatory intra-arterial recording.Am J Cardiol 1983:51:1323\u20131327.","journal-title":"Am J Cardiol"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02018297.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02018297\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02018297","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T11:45:52Z","timestamp":1557834352000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02018297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,9]]},"references-count":22,"journal-issue":{"issue":"S5","published-print":{"date-parts":[[1990,9]]}},"alternative-id":["BF02018297"],"URL":"https:\/\/doi.org\/10.1007\/bf02018297","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990,9]]}}}